Objective To review the background of telomerase activation and the me
thodology involved in its determination, and the clinico-pathological
significance of telomerase activation in human cancers. Data sources A
n English-language literature search using MEDLINE (1966-1997) and bib
liographic reviews of textbooks and review articles. Results Progressi
ve shortening of telomeres was associated with continuous cell divisio
n in normal somatic cells. Telomerase was activated in most cancer cel
ls and immortal germ cells to maintain their telomeric lengths. The oc
currence and clinical pathological significance of telomerase activati
on was evaluated in various types of human cancer. Conclusions Telomer
ase activation is a common event in human cancers and may be as a usef
ul marker for malignant cells. Telomerase may also be a therapeutic ta
rget for cancer treatment.